Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

109 results about "Orciprenaline" patented technology

Metaproterenol is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease, bronchitis, emphysema).

Compositions and methods for the treatment of depression

ActiveUS12161622B2Nervous disorderPharmaceutical delivery mechanismNorepinephrine reuptake inhibitorDepressant
The disclosure provides methods for treating major depressive disorder in a human patient having moderate or severe anhedonia. The methods comprise administering to the patient in need thereof an effective amount of aticaprant, or a pharmaceutically acceptable salt thereof. In some embodiments, the patient had an inadequate response to other antidepressant therapy prior to treatment with aticaprant. In other embodiments, the other antidepressant therapy comprised a selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), or a combination thereof.
Owner:JANSSEN PHARMACEUTICALS INC

Preparation method of mineralized collagen scaffold material with bionic structure, mineralized collagen scaffold material and application of mineralized collagen scaffold material

The invention provides a preparation method of a mineralized collagen scaffold material with a bionic structure, and belongs to the field of biomedical engineering.The preparation method comprises the steps that an amorphous calcium phosphate solution stabilized by polyacrylic acid is prepared, and the molar ratio of Ca to P in the amorphous calcium phosphate solution is 1.67: 1; preparing a collagen solution containing noradrenaline; carrying out isoelectric focusing treatment on the collagen solution under a constant voltage to form a dense membrane, and stretching the dense membrane to generate 120-200% deformation, so as to obtain a collagen membrane with a bionic structure; and soaking the collagen membrane in the amorphous calcium phosphate solution, and then performing freeze drying to obtain the noradrenaline-mineralized collagen scaffold material. The mineralized collagen scaffold material prepared by the method has excellent biocompatibility, osteogenesis inductivity and sufficient mechanical strength, can effectively promote bone tissue defect repair, and has a good application prospect in the field of bone tissue engineering. The invention further provides the mineralized collagen scaffold material with the bionic structure and application of the mineralized collagen scaffold material.
Owner:SOUTHWEST JIAOTONG UNIV

Compositions and methods for the treatment of depression

ActiveUS12150929B2Nervous disorderPharmaceutical delivery mechanismNorepinephrine reuptake inhibitorDepressant
The disclosure provides methods for treating major depressive disorder in a human patient having moderate or severe anhedonia. The methods comprise administering to the patient in need thereof an effective amount of aticaprant, or a pharmaceutically acceptable salt thereof. In some embodiments, the patient had an inadequate response to other antidepressant therapy prior to treatment with aticaprant. In other embodiments, the other antidepressant therapy comprised a selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), or a combination thereof.
Owner:JANSSEN PHARMACEUTICALS INC

Tree shrew depression model construction method

InactiveCN119074733Aeffect will not affectinhibition of reuptakeOrganic active ingredientsAnimal husbandryAcetic acidAdrenergic
The invention discloses a tree shrew depression model construction method which comprises the following steps: (1) dissolving 10mg of reserpine in 10mu l of glacial acetic acid, adding sterile distilled water to fix the volume to 10ml to prepare 1mg / ml mother liquor, and preparing noradrenaline into 1mg / ml mother liquor by using 5% glucose injection; (2) diluting the reserpine mother liquor in the step (1) by 10 times with sterile distilled water, and then injecting the diluted reserpine mother liquor into the abdominal cavity of the tree shrew; and after 2 hours, diluting the noradrenaline mother liquor in the step (1) by 50 times by using sterile distilled water, and injecting the diluted noradrenaline mother liquor into the abdominal cavity of the tree shrew for 14 days. Noradrenaline is given while reserpine is given, noradrenaline cannot pass through a blood brain barrier and does not affect the effect of reserpine on the brain, and experiments prove that after reserpine and noradrenaline are injected into the tree shrew intraperitoneal cavity at the same time, the death rate of a tree shrew depression model is greatly reduced.
Owner:LABREAL BIOTECH KUNMING CO LTD +1

Composition for regulating skin mood as well as preparation method and application thereof

The invention relates to the technical field of cosmetics, and particularly discloses a composition for regulating skin emotion and a preparation method and application thereof. Comprising the following components: aesculus chinensis fruit dry powder, radix sophorae flavescentis dry powder, mint leaf dry powder, geranium leaf dry powder and a solvent. The invention provides a composition for regulating skin mood, which is prepared by compounding dried aesculus chinensis fruit powder, dried radix sophorae flavescentis root powder, dried mint leaf powder and dried geranium leaf powder, and the prepared composition can regulate endogenous'happy hormone 'neurotransmitters (beta-enorphin, cortisol, 5-hydroxytryptamine, noradrenaline and the like) of a human body through skin absorption. Moreover, unhealthy states such as skin sensitivity, tension, redness and swelling, stabbing pain and pruritus caused by mood and pressure problems can be effectively relieved, expression of pressure regulating genes is activated, skin mood is relieved, skin detoxification is promoted, external pollution is defended, oxidation resistance and inflammation diminishing are achieved, and skin is relieved and repaired.
Owner:SHENZHEN LLG BIOTECHNOLOGY CO LTD

Detection method of catecholamine substances and metabolites thereof, freeze-dried powder and application of freeze-dried powder

The invention discloses a detection method of catecholamine substances and metabolites thereof, freeze-dried powder and application of the freeze-dried powder. The detection method of catecholamine and metabolites thereof comprises the following step: detecting a sample to be detected by adopting a liquid chromatography-tandem mass spectrometry method. According to the present invention, the sample pretreatment and the detection condition optimization are performed so as to achieve the efficient and accurate detection of noradrenaline, epinephrine, variepinephrine, noradrenaline, dopamine and 3-methoxytyramine, the sensitivity is high, the specificity is good, and the new reliable detection method is provided for the detection of catecholamine and metabolites thereof in the blood sample.
Owner:GUANGDONG TAIWEN BIOLOGICAL ENG CO LTD

Preparation method and application of absorbable suture line loaded with mesenchymal stem cell exosome

The invention discloses a preparation method and application of a mesenchymal stem cell exosome-loaded absorbable suture line, noradrenaline is utilized to activate the surface of a collagen suture line, then human umbilical cord mesenchymal stem cell exosomes are assembled to the surface of the activated suture line through a soaking method, and the absorbable suture line with the surface functionalization is constructed. After the suture line is used, the wound healing effect is good, the blood vessel and cell recovery degree is good, proliferation and migration of fibroblasts can be remarkably promoted, proliferation of T lymphocytes and Th1 cells is effectively inhibited, and a powerful guarantee is provided for tissue repair.
Owner:岳寒

Infusion dosage form of norepinephrine

The present invention provides a ready to use stable aqueous dosage form of norepinephrine comprising an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, one or more sulfite antioxidants and an ion chelator. The present invention also provides an infusion container filled with an aqueous solution of norepinephrine or its pharmaceutically acceptable salt, wherein the said solution is stable for a prolonged period of time and can be terminally sterilized by autoclaving.
Owner:SUN PHARMACEUTICAL INDUSTRIES LTD

Method for synchronously detecting eight catecholamines and metabolites thereof based on liquid chromatography-tandem mass spectrometry and application of method

The invention provides a method for synchronously detecting eight catecholamines and metabolites thereof based on liquid chromatography-tandem mass spectrometry and application of the method. The detection method comprises the following steps: mixing a plasma or urine sample to be detected with an internal standard and acetonitrile; centrifuging, taking supernate, blowing liquid with nitrogen, and adjusting the pH value; mixing the supernate with a propionic anhydride solution, and carrying out derivatization reaction to obtain a test solution; performing liquid chromatography-tandem mass spectrometry detection on the test solution and the standard solution, separating dopamine, epinephrine, noradrenaline, epinephrine, noradrenaline, 3-methoxytyramine, homovanillic acid and vanillic mandelic acid by liquid chromatography, and determining the concentration of the standard substance as an X axis by using a mass spectrometry isotope internal standard quantification method. The ratio of the peak area of the standard substance to the peak area of the internal standard substance is the Y axis, establishing a standard curve, and calculating the concentrations of catecholamine and the metabolites thereof in the test solution. The method is high in detection efficiency, high in sensitivity and good in equipment compatibility, the detection time is shortened, and the cost can also be saved.
Owner:JIANGSU YINUOKE BIOTECHNOLOGY CO LTD

Construction method and application of lonely mouse model

The invention relates to a construction method and application of a loneliness mouse model, and the method comprises the steps: placing an experimental mouse in an isolation region in a transparent acrylic isolation cover through an environment in which physical isolation and social deprivation stimulation coexist, forming a visually accessible but physically isolated social environment with five normal living mice, and continuously inducing chronic loneliness for 4 weeks. The effectiveness of the model is verified through a multi-dimensional evaluation system, including behavioristics (open field, elevated maze and three-box experiment), neuroendocrine (serum noradrenaline and angiotensin II), immune inflammatory factors (IL-1beta, IL-6, TNF-alpha and CCL5) and nerve activation (blue spot, almond nucleus, lateral nucleus septum, medial prefrontal cortex and center joint dorsal nucleus C-Fos staining) indexes. According to the intervention method, dynamic environment abundance and social stimulation are adopted, running wheels are arranged, a modular abundance device is arranged, and a social environment of new mice is introduced, so that pathological phenotypes caused by loneliness are reversed. And a systematic experiment tool is provided for exploring association of aloneness and diseases.
Owner:AFFILIATDE CANCER HOSPITAL & INST OF GUANGZHOU MEDICAL UNIV

Ampleloxetine for use in the treatment of multiple system atrophy

Methods for treating a subject with multiple system atrophy (MSA) using ampleloxetine or a pharma- ceutically acceptable salt thereof are disclosed. The disclosed methods include using ampleloxetine or a pharma- ceutically acceptable salt thereof to (i) treat symptoms of neurogenic orthostatic hypotension in a subject with MSA, (ii) reduce the magnitude of the decline in quality of life in a subject with MSA, and / or (iii) increase the level of norepinephrine in a subject with MSA.
Owner:THERAVANCE BIOPHARMA R&D IP LLC

Preparation method and application of conjugate targeting pelvic autonomic nerves

The application discloses a preparation method and application of a conjugate targeting pelvic autonomic nerves, wherein the conjugate is NE-RH formed by coupling of rhein and norepinephrine, the conjugate can realize precise targeting of norepinephrine neurons, improve the accumulation effect of RH in the norepinephrine neurons, and further enhance the nerve protection effect of RH. The conjugate has a molecular weight of less than 1000 Da, can help to penetrate the blood-brain barrier, and can avoid the defects of being easily removed by a mononuclear phagocyte system and having a short half-life. The production process of the conjugate is simple, the chemical coupling reaction is clear, the yield can reach 38%, and the purity of the product is greater than 99%, so that the conjugate is convenient to popularize and use. The conjugate and the preparation method have important significance for the damage repair of pelvic autonomic nerves.
Owner:GUANGDONG PHARMA UNIV +1

Noradrenergic and specific serotonergic anxiolytic and antidepressant, method for the production and use thereof

The present invention relates to a novel Noradrenergic and Specific Serotonergic Anxiolytic and Antidepressant (NaSSA) and a method for the production and use thereof for treating mental disorders.The subject of this invention is a novel noradrenergic and specific serotonergic drug for the treatment of mental disorders in humans, which is 2,8-dimethyl-5-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride (A·HCl), a polymorphous modification thereof, and methods for the production and use thereof.
Owner:ALLA CHEM LLC +2

A Bioluminescent Probe for Detecting Norepinephrine, Its Preparation Method and Use

The present invention provides a bioluminescence probe for detecting norepinephrine, its preparation method and use, belonging to the field of biological detection. The bioluminescence probe of the present invention has high selectivity and high responsiveness to norepinephrine, can specifically recognize norepinephrine, has high sensitivity and low detection limit, and can be used for the precise detection of norepinephrine. In the range of pH 1.0 to 7.4, the bioluminescence probe of the present invention has excellent stability and can meet the application requirements under different physiological environments in vivo. At the same time, the norepinephrine bioluminescence probe of the present invention can also visually track exogenous norepinephrine at the in vivo level, and perform dynamic visual analysis on patients with diseases related to abnormal expression of norepinephrine involving nerves, tumors, blood pressure and heart diseases, which is beneficial to the clinical detection of norepinephrine and has broad application prospects.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Combination of latrepirdine and a pharmacokinetic stabilizer

The present disclosure relates to a pharmaceutical composition comprising a therapeutically effective amount of latrepirdine or a pharmaceutically acceptable salt thereof and an effective amount of a PK stabilizer. The PK stabilizer may be selected from the group consisting of paroxetine, fluoxetine, and quinidine or a pharmaceutically acceptable salt thereof. The PK stabilizer in the composition results in improved pharmacokinetic profile and enhanced therapeutic effect of latrepirdine. The disclosure further relates to treatment of disorders associated with noradrenergic hyperarousal using the pharmaceutical composition.
Owner:BIOXCEL THERAPEUTICS INC +2

Noradrenaline oscillation time-frequency-phase three-dimensional coupling sleep cooperative regulation and control device

The invention belongs to the technical field of human body electroencephalogram signal processing and brain regulation and control, and provides a noradrenaline oscillation time-frequency-phase three-dimensional coupling sleep coordinated regulation and control device which comprises the following steps: calculating a three-dimensional coupling coefficient by combining a time domain correlation coefficient, a frequency domain correlation coefficient and an instantaneous phase difference between multi-modal physiological signals; determining the coupling state of the signal based on the three-dimensional coupling coefficient and a preset threshold value; predicting to obtain an optimal regulation factor and a modal weight based on a coupling coefficient matrix constructed based on a time domain correlation coefficient and a frequency domain correlation coefficient and a constructed three-dimensional coupling double-layer optimization architecture in combination with the multi-modal physiological signal; calculating the optimized stimulation intensity in combination with the modal weight, the optimal regulation factor and the multi-modal signal characteristic parameters; and adaptively selecting a stimulation mode and outputting a stimulation signal according to the coupling state of the current multi-mode signal and the optimized stimulation intensity. Accurate matching of stimulation parameters and nerve-blood vessel-cerebrospinal fluid system collaborative rhythm is realized.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Reagent combination for depression detection, manufacturing method, detection system and application thereof

The application relates to a reagent combination for detecting depression, a manufacturing method, a detection system and application thereof, and belongs to the technical field of instrument detection. The reagent combination for detecting depression comprises a calibrator, a quality control sample and an extraction solution of a to-be-detected compound serving as a biomarker; wherein the to-be-detected compound is at least three kinds selected from 5-hydroxyanthranilic acid, methionine, gamma-aminobutyric acid, 3,4-dihydroxyphenylacetic acid, 2-picolinic acid, quinolinic acid, kynurenine, 5-hydroxytryptamine, 3-hydroxykynurenine, 3-hydroxyanthranilic acid, dopamine and norepinephrine. The reagent combination for detecting depression and the detection system can significantly improve the accuracy of diagnosis, are convenient to detect, have good repeatability of detection data, are high in specificity, and are accurate in clinical diagnosis results.
Owner:HEFEI NOVA MS BIOTECH MEDICAL EQUIP CO LTD +1

Method for efficiently preparing chiral alpha-nitroalcohol

The invention provides a method for efficiently preparing chiral alpha-nitroalcohol, and relates to the technical field of chemical synthesis. The invention provides a method for converting nitroketone into nitroalcohol, and the obtained alpha-nitroalcohol compound can be used as an intermediate for synthesizing a plurality of important drugs (such as noradrenaline) and has very high economic value. The asymmetric catalytic hydrogenation method provided by the invention is high in efficiency, quantitative in yield and excellent in enantioselectivity, and greatly reduces the difficulty and cost of synthesis of various drugs. # imgabs0 #
Owner:SHENZHEN GREENCAT PHARMACEUTICAL TECHNOLOGY CO LTD

Methods and compositions for treating agitation

The present disclosure relates to the treatment of agitation caused by noradrenergic hyperarousal in an agitated subject. The present disclosure provides oromucosal dosage forms comprising effective amounts of latrepirdine either alone or in combination with dexmedetomidine or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable carriers and / excipients. Methods of their use are also provided. The present disclosure also provides a method of treating depression by administering oromucosally a therapeutically effective amount of dexmedetomidine alone or in combination with latrepirdine.
Owner:BIOXCEL THERAPEUTICS INC

Ultrasonic-electrical stimulation synergetic lymphatic system enhanced closed-loop regulation and control system

The invention belongs to the technical field of human body electroencephalogram signal processing and brain regulation and control. The invention provides an ultrasonic-electrical stimulation collaborative lymphatic system enhanced closed-loop regulation and control system, which integrates noradrenaline oscillation core driving signals to realize sleep staging and conversion detection, decides an ultrasonic-electrical stimulation collaborative mode based on a staging coupling index, completes parameter linear transition in a conversion period, and improves sleep quality. Stimulation parameters are dynamically optimized in combination with reinforcement learning and a PID fusion algorithm. According to the device, the defects of core signal deficiency, inaccurate stimulation coordination, one-sided coupling analysis and poor safety adaptability of an existing device are overcome, the lymphatic system metabolic waste removal efficiency is remarkably improved, the sleep interruption risk is reduced, regulation and control are accurate, safety and noninvasive are achieved, the device is suitable for prevention and adjuvant therapy of neurodegenerative diseases such as Alzheimer's disease, and the device has a wide application prospect. And the method can also be expanded to be used for lymphatic-like function mechanism research and early disease screening.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Application of Jinfeng pill and preparation thereof in preparation of medicine for treating polycystic ovarian syndrome

The invention discloses an application of Jinfeng pills and a preparation thereof in preparing a medicine for treating polycystic ovarian syndrome, and belongs to the technical field of medicines. A kidney-tonifying traditional Chinese medicine can release hormones and related neurotransmitters (such as noradrenaline, dopamine and the like) through gonadotrophin, and has a regulating effect on synthesis and release of the hormones and related neurotransmitters (such as noradrenaline, dopamine and the like); the gonad promoting function of hypothalamic pituitary is adjusted; the gene expression of hypothalamus pituitary gonadotropin, glandular pituitary follicle-stimulating hormone and luteinizing hormone can also be regulated at the transcriptional level; therefore, the kidney-tonifying traditional Chinese medicine can improve the estrogen level of an organism or has an estrogen-like effect and can promote follicle development, the Jinfeng pill preparation shows a good treatment effect in treatment of cyclophosphamide-induced premature ovarian insufficiency, the abnormal change of cyclophosphamide-induced rat serum hormones is remarkably improved, recruitment of primordial follicles is promoted, and the curative effect of the kidney-tonifying traditional Chinese medicine on early ovarian insufficiency induced by cyclophosphamide is improved. And the follicle inventory loss is reduced.
Owner:TONGYITANG PHARM CO LTD

Sleep deprivation marker identification method based on WGCNA and machine learning

The invention discloses a sleep deprivation marker identification method based on WGCNA and machine learning, and relates to the technical field of sleep deprivation markers. The method specifically comprises the following steps: S1, data acquisition and test design; s2, differential gene identification; s3, function enrichment; s4, WGCNA analysis is carried out; s5, LASSO calculation is carried out; s6, performing a sleep deprivation mouse model experiment; s7, determining noradrenaline by using an enzyme-linked immunosorbent assay method; s8, a Western blot western blot test is carried out; s9, analyzing immune characteristics; and S10, statistical analysis. According to the invention, two hub genes KLRD1 and SPON2 related to sleep deprivation are screened through bioinformatics and machine learning methods, the important role of KLRD1 in SD is confirmed, a new SD biomarker SPON2 is identified, and the immune spectrum in the SD state is comprehensively analyzed for the first time on the genetic level.
Owner:CHONGQING MEDICAL UNIVERSITY

Use of a norepinephrine inhibitor in the manufacture of a medicament for treating or alleviating a deficiency of corneal limbal stem cells

The application discloses application of a norepinephrine inhibitor in preparation of a medicine for treating or relieving corneal limbal stem cell deficiency, and belongs to the technical field of medicines.The experiment proves that sympathetic nerves are excessively activated in a mouse model of corneal limbal stem cell deficiency, and the release of norepinephrine is increased, and the experiment proves that 6-hydroxydopamine hydrochloride can destroy sympathetic nerves to inhibit the release of norepinephrine, and a tyrosine hydroxylase inhibitor can inhibit the synthesis of norepinephrine, and both can further relieve the symptoms of corneal limbal stem cell deficiency.The norepinephrine inhibitor can improve the corneal limbal microenvironment, reduce corneal neovascularization, reduce corneal epithelialization, enhance corneal transparency and relieve corneal edema, and provides a new direction and a new way for the pathogenic mechanism and intervention target of corneal limbal stem cell deficiency, and has a wide application prospect.
Owner:EYE INST OF SHANDONG FIRST MEDICAL UNIV

Kit and method for extracting catecholamine and metabolite thereof based on paramagnetic particle method and method for detecting catecholamine and metabolite thereof by LC-MS / MS

The invention relates to the technical field of analysis and detection, in particular to a kit and a method for extracting catecholamine and metabolites thereof based on a paramagnetic particle method and a method for detecting catecholamine and metabolites thereof by LC-MS / MS (liquid chromatography-mass spectrometry / mass spectrometry). The kit comprises magnetic beads, an activating solution, an eluent, a washing solution, a leacheate I, a leacheate II and a derivatization reagent, the catecholamine and the metabolite thereof comprise one or more of dopamine hydrochloride, epinephrine, noradrenaline hydrochloride, methoxynoradrenaline hydrochloride, methoxyepinephrine hydrochloride and 3-methoxytyramine hydrochloride. The in-vivo concentration of catecholamine and metabolites thereof in human plasma and urine is detected in a high-flux manner by adopting a magnetic bead and derivation method, and the kit has the characteristics of high sensitivity, good repeatability, high accuracy, good specificity and the like.
Owner:北京豪思生物科技股份有限公司 +3

Compositions and methods for the treatment of depression

PendingUS20250177350A1Nervous disorderCapsule deliveryNorepinephrine reuptake inhibitorDepressant
The disclosure provides methods for treating major depressive disorder in a human patient having moderate or severe anhedonia. The methods comprise administering to the patient in need thereof an effective amount of aticaprant, or a pharmaceutically acceptable salt thereof. In some embodiments, the patient had an inadequate response to other antidepressant therapy prior to treatment with aticaprant. In other embodiments, the other antidepressant therapy comprised a selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), or a combination thereof.
Owner:JANSSEN PHARMACEUTICALS INC

Monoamine transmitter reuptake inhibitor compound and preparation method therefor and use thereof

The present invention provides a monoamine transmitter reuptake inhibitor and a preparation method therefor and a pharmaceutical composition thereof, and further relates to a use of the compound or the pharmaceutical composition in preparation of a drug for preventing or treating dopamine (DA), norepinephrine (NE), 5-hydroxytryptamine (5-HT), and / or sigma-1 receptor-mediated related diseases.
Owner:SHANDONG QUANZHONG BIOMEDICAL TECHNOLOGY CO LTD